Who Makes Femara?
The prescription medicine Femara® (letrozole) is approved to treat certain types of breast cancer in women who have gone through menopause. It is currently available as a brand-name medication only. Femara is made by Novartis Pharmaceuticals, and it belongs to a group of medications called aromatase inhibitors. These drugs are designed to block enzymes that produce estrogen -- a hormone that is known to increase the growth of certain types of breast cancer tumors.
(Click Femara to read the full eMedTV article on this breast cancer medication. This resource offers detailed information on who can use the drug, how it works, and the results of clinical studies.)